miRNA 221 alleviated calcium overload in myocardium and inhibited the expression of apoptosis-related genes in MIRI mice. by Hongyu Li (1332669)

Subjects:

The heart rate was similar among the groups. by Hongyu Li (1332669)

Subjects:

S1 File - by Hongyu Li (1332669)

Subjects:

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

Subjects:

miRNA 221 alleviated myocardial injury and inhibited apoptosis and necrosis of cardiac cells in MIRI mice. by Hongyu Li (1332669)

Subjects:

Primer sequences for RT-qPCR. by Hongyu Li (1332669)

Subjects:

miRNA 221 improved left ventricular contractile function in MIRI mice. by Hongyu Li (1332669)

Subjects:

Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Subjects:

Subgroup and sensitivity analyses for the primary outcomes. by Jin-Min Gu (17915039)

Subjects:

Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

Subjects:

Flow diagram for the identification of studies included. by Jin-Min Gu (17915039)

Subjects:

Forest plot of the hospital stay length in distinct stages of patients. by Jin-Min Gu (17915039)

Subjects:

Clinical manifestations and outcomes of each p/lpCNVs case. by Shiwei Ren (9308280)

Significant associations in GWAS. by Dai Nogimura (21445649)

Subjects:

Data Sheet 1_Classical complement activation in light and heavy chain deposition disease with acquired cutis laxa and bronchiolitis obliterans: a case report of monoclonal gammopathy of clinical significance.pdf by Yuxiong Chen (11848886)

“…Progressive dermatologic manifestations prompted repeat skin biopsies, revealing deposition of γ1 heavy chains, restrictive lambda light chains and complement components (C3, C4 and C1q) along dermal elastic fibers, establishing monoclonal gammopathy of dermatologic significance (MGODS) before systemic involvement. This case illustrates a rare constellation of MGRS, MGODS, and BO in a young adult and provides unique histologic and serologic evidence of classical complement pathway activation. …”

Fundamental Characteristics of Participants by PAL. by Haiwei Li (282229)

Subjects:

Fundamental Characteristics of Participants with and without CVD. by Haiwei Li (282229)

Subjects:

Data. by Haiwei Li (282229)

Subjects:

Flow diagram of the participants screening procedures. by Haiwei Li (282229)

Subjects:

Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. by Haiwei Li (282229)

Subjects: